nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—CYP19A1—Tamoxifen—pancreatic cancer	0.237	0.296	CbGbCtD
Methyltestosterone—CYP2B6—Tamoxifen—pancreatic cancer	0.0976	0.122	CbGbCtD
Methyltestosterone—ALB—Erlotinib—pancreatic cancer	0.0813	0.102	CbGbCtD
Methyltestosterone—CYP2B6—Irinotecan—pancreatic cancer	0.0749	0.0937	CbGbCtD
Methyltestosterone—ALB—Irinotecan—pancreatic cancer	0.0735	0.0918	CbGbCtD
Methyltestosterone—ALB—Fluorouracil—pancreatic cancer	0.0705	0.0881	CbGbCtD
Methyltestosterone—CYP2B6—Doxorubicin—pancreatic cancer	0.0409	0.0512	CbGbCtD
Methyltestosterone—CYP3A4—Tamoxifen—pancreatic cancer	0.03	0.0375	CbGbCtD
Methyltestosterone—CYP3A4—Erlotinib—pancreatic cancer	0.0255	0.0319	CbGbCtD
Methyltestosterone—Peliosis hepatis—Tamoxifen—pancreatic cancer	0.0248	0.165	CcSEcCtD
Methyltestosterone—CYP3A4—Irinotecan—pancreatic cancer	0.023	0.0288	CbGbCtD
Methyltestosterone—CYP3A4—Docetaxel—pancreatic cancer	0.0169	0.0211	CbGbCtD
Methyltestosterone—CYP3A4—Sunitinib—pancreatic cancer	0.0168	0.021	CbGbCtD
Methyltestosterone—CYP3A4—Doxorubicin—pancreatic cancer	0.0126	0.0157	CbGbCtD
Methyltestosterone—Oligospermia—Gemcitabine—pancreatic cancer	0.0102	0.0679	CcSEcCtD
Methyltestosterone—Azoospermia—Gemcitabine—pancreatic cancer	0.00793	0.0529	CcSEcCtD
Methyltestosterone—Menstruation irregular—Tamoxifen—pancreatic cancer	0.00561	0.0374	CcSEcCtD
Methyltestosterone—Hirsutism—Erlotinib—pancreatic cancer	0.00529	0.0353	CcSEcCtD
Methyltestosterone—Oligospermia—Epirubicin—pancreatic cancer	0.00488	0.0325	CcSEcCtD
Methyltestosterone—Oligospermia—Doxorubicin—pancreatic cancer	0.00451	0.0301	CcSEcCtD
Methyltestosterone—Azoospermia—Epirubicin—pancreatic cancer	0.00379	0.0253	CcSEcCtD
Methyltestosterone—Amenorrhoea—Tamoxifen—pancreatic cancer	0.00354	0.0236	CcSEcCtD
Methyltestosterone—Azoospermia—Doxorubicin—pancreatic cancer	0.00351	0.0234	CcSEcCtD
Methyltestosterone—Venous thromboembolism—Epirubicin—pancreatic cancer	0.00348	0.0232	CcSEcCtD
Methyltestosterone—Venous thromboembolism—Doxorubicin—pancreatic cancer	0.00322	0.0214	CcSEcCtD
Methyltestosterone—Menstruation irregular—Docetaxel—pancreatic cancer	0.00274	0.0182	CcSEcCtD
Methyltestosterone—Embolism venous—Epirubicin—pancreatic cancer	0.00202	0.0135	CcSEcCtD
Methyltestosterone—Embolism venous—Doxorubicin—pancreatic cancer	0.00187	0.0125	CcSEcCtD
Methyltestosterone—Amenorrhoea—Docetaxel—pancreatic cancer	0.00172	0.0115	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.00164	0.011	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.0016	0.0107	CcSEcCtD
Methyltestosterone—Haemoglobin—Tamoxifen—pancreatic cancer	0.00157	0.0105	CcSEcCtD
Methyltestosterone—Haemorrhage—Tamoxifen—pancreatic cancer	0.00156	0.0104	CcSEcCtD
Methyltestosterone—Haemoglobin—Erlotinib—pancreatic cancer	0.00155	0.0103	CcSEcCtD
Methyltestosterone—Haemorrhage—Erlotinib—pancreatic cancer	0.00154	0.0103	CcSEcCtD
Methyltestosterone—Alopecia—Tamoxifen—pancreatic cancer	0.00138	0.00919	CcSEcCtD
Methyltestosterone—Alopecia—Erlotinib—pancreatic cancer	0.00136	0.00909	CcSEcCtD
Methyltestosterone—Haemoglobin—Sunitinib—pancreatic cancer	0.00134	0.00895	CcSEcCtD
Methyltestosterone—Haemorrhage—Sunitinib—pancreatic cancer	0.00134	0.00891	CcSEcCtD
Methyltestosterone—Angiopathy—Sunitinib—pancreatic cancer	0.00121	0.00808	CcSEcCtD
Methyltestosterone—Alopecia—Sunitinib—pancreatic cancer	0.00118	0.00787	CcSEcCtD
Methyltestosterone—Amenorrhoea—Epirubicin—pancreatic cancer	0.00116	0.00775	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.00116	0.00775	CcSEcCtD
Methyltestosterone—Anxiety—Tamoxifen—pancreatic cancer	0.00115	0.00768	CcSEcCtD
Methyltestosterone—Anxiety—Erlotinib—pancreatic cancer	0.00114	0.0076	CcSEcCtD
Methyltestosterone—Haemoglobin—Irinotecan—pancreatic cancer	0.00111	0.00738	CcSEcCtD
Methyltestosterone—Haemorrhage—Irinotecan—pancreatic cancer	0.0011	0.00734	CcSEcCtD
Methyltestosterone—Haemoglobin—Gemcitabine—pancreatic cancer	0.00108	0.00718	CcSEcCtD
Methyltestosterone—Amenorrhoea—Doxorubicin—pancreatic cancer	0.00108	0.00717	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.00108	0.00717	CcSEcCtD
Methyltestosterone—Haemorrhage—Gemcitabine—pancreatic cancer	0.00107	0.00715	CcSEcCtD
Methyltestosterone—Haemoglobin—Fluorouracil—pancreatic cancer	0.00106	0.00706	CcSEcCtD
Methyltestosterone—Haemorrhage—Fluorouracil—pancreatic cancer	0.00105	0.00703	CcSEcCtD
Methyltestosterone—Angiopathy—Irinotecan—pancreatic cancer	0.000998	0.00666	CcSEcCtD
Methyltestosterone—Paraesthesia—Tamoxifen—pancreatic cancer	0.000995	0.00664	CcSEcCtD
Methyltestosterone—Angiopathy—Gemcitabine—pancreatic cancer	0.000973	0.00649	CcSEcCtD
Methyltestosterone—Alopecia—Irinotecan—pancreatic cancer	0.000973	0.00648	CcSEcCtD
Methyltestosterone—Alopecia—Gemcitabine—pancreatic cancer	0.000947	0.00632	CcSEcCtD
Methyltestosterone—Alopecia—Fluorouracil—pancreatic cancer	0.000931	0.00621	CcSEcCtD
Methyltestosterone—Paraesthesia—Sunitinib—pancreatic cancer	0.000852	0.00568	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000782	0.00521	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000766	0.00511	CcSEcCtD
Methyltestosterone—Haemoglobin—Docetaxel—pancreatic cancer	0.000765	0.0051	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000762	0.00508	CcSEcCtD
Methyltestosterone—Haemorrhage—Docetaxel—pancreatic cancer	0.000761	0.00507	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000749	0.00499	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000709	0.00473	CcSEcCtD
Methyltestosterone—Paraesthesia—Irinotecan—pancreatic cancer	0.000702	0.00468	CcSEcCtD
Methyltestosterone—Headache—Tamoxifen—pancreatic cancer	0.000694	0.00463	CcSEcCtD
Methyltestosterone—Angiopathy—Docetaxel—pancreatic cancer	0.00069	0.0046	CcSEcCtD
Methyltestosterone—Headache—Erlotinib—pancreatic cancer	0.000687	0.00458	CcSEcCtD
Methyltestosterone—Paraesthesia—Gemcitabine—pancreatic cancer	0.000684	0.00456	CcSEcCtD
Methyltestosterone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000672	0.00448	CcSEcCtD
Methyltestosterone—Alopecia—Docetaxel—pancreatic cancer	0.000672	0.00448	CcSEcCtD
Methyltestosterone—Nausea—Tamoxifen—pancreatic cancer	0.000658	0.00439	CcSEcCtD
Methyltestosterone—Nausea—Erlotinib—pancreatic cancer	0.000651	0.00434	CcSEcCtD
Methyltestosterone—Headache—Sunitinib—pancreatic cancer	0.000595	0.00396	CcSEcCtD
Methyltestosterone—Nausea—Sunitinib—pancreatic cancer	0.000564	0.00376	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00054	0.0036	CcSEcCtD
Methyltestosterone—Haemoglobin—Epirubicin—pancreatic cancer	0.000516	0.00344	CcSEcCtD
Methyltestosterone—Haemorrhage—Epirubicin—pancreatic cancer	0.000513	0.00342	CcSEcCtD
Methyltestosterone—Headache—Irinotecan—pancreatic cancer	0.00049	0.00327	CcSEcCtD
Methyltestosterone—Paraesthesia—Docetaxel—pancreatic cancer	0.000485	0.00324	CcSEcCtD
Methyltestosterone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000477	0.00318	CcSEcCtD
Methyltestosterone—Headache—Gemcitabine—pancreatic cancer	0.000477	0.00318	CcSEcCtD
Methyltestosterone—Haemorrhage—Doxorubicin—pancreatic cancer	0.000475	0.00317	CcSEcCtD
Methyltestosterone—Headache—Fluorouracil—pancreatic cancer	0.000469	0.00313	CcSEcCtD
Methyltestosterone—Angiopathy—Epirubicin—pancreatic cancer	0.000466	0.0031	CcSEcCtD
Methyltestosterone—Nausea—Irinotecan—pancreatic cancer	0.000464	0.0031	CcSEcCtD
Methyltestosterone—Alopecia—Epirubicin—pancreatic cancer	0.000453	0.00302	CcSEcCtD
Methyltestosterone—Nausea—Gemcitabine—pancreatic cancer	0.000452	0.00302	CcSEcCtD
Methyltestosterone—Nausea—Fluorouracil—pancreatic cancer	0.000445	0.00297	CcSEcCtD
Methyltestosterone—Angiopathy—Doxorubicin—pancreatic cancer	0.000431	0.00287	CcSEcCtD
Methyltestosterone—Alopecia—Doxorubicin—pancreatic cancer	0.00042	0.0028	CcSEcCtD
Methyltestosterone—Anxiety—Epirubicin—pancreatic cancer	0.000379	0.00253	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000365	0.00243	CcSEcCtD
Methyltestosterone—Anxiety—Doxorubicin—pancreatic cancer	0.000351	0.00234	CcSEcCtD
Methyltestosterone—Headache—Docetaxel—pancreatic cancer	0.000339	0.00226	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000337	0.00225	CcSEcCtD
Methyltestosterone—Paraesthesia—Epirubicin—pancreatic cancer	0.000327	0.00218	CcSEcCtD
Methyltestosterone—Nausea—Docetaxel—pancreatic cancer	0.000321	0.00214	CcSEcCtD
Methyltestosterone—Paraesthesia—Doxorubicin—pancreatic cancer	0.000303	0.00202	CcSEcCtD
Methyltestosterone—Headache—Epirubicin—pancreatic cancer	0.000228	0.00152	CcSEcCtD
Methyltestosterone—Nausea—Epirubicin—pancreatic cancer	0.000217	0.00144	CcSEcCtD
Methyltestosterone—Headache—Doxorubicin—pancreatic cancer	0.000211	0.00141	CcSEcCtD
Methyltestosterone—Nausea—Doxorubicin—pancreatic cancer	0.0002	0.00134	CcSEcCtD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000145	0.00291	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—pancreatic cancer	0.000145	0.0029	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000145	0.0029	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000145	0.0029	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—pancreatic cancer	0.000142	0.00285	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000142	0.00284	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CCND1—pancreatic cancer	0.000134	0.00269	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CTNNB1—pancreatic cancer	0.000133	0.00267	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—PTEN—pancreatic cancer	0.00013	0.0026	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.000125	0.0025	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.000124	0.00249	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—CHD3—pancreatic cancer	0.000121	0.00242	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000121	0.00242	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—SRC—pancreatic cancer	0.00012	0.00241	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000118	0.00237	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000118	0.00237	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000118	0.00236	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—pancreatic cancer	0.000117	0.00235	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000116	0.00233	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—STAT3—pancreatic cancer	0.000116	0.00232	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000114	0.00229	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.00011	0.0022	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—EGFR—pancreatic cancer	0.000105	0.00211	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000105	0.00211	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000103	0.00206	CbGpPWpGaD
Methyltestosterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000102	0.00205	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.000102	0.00204	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.000102	0.00204	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—NR5A2—pancreatic cancer	0.000101	0.00203	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—AKT1—pancreatic cancer	0.000101	0.00203	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—EGF—pancreatic cancer	9.8e-05	0.00196	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	9.72e-05	0.00195	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	9.34e-05	0.00187	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	9.2e-05	0.00184	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	9.11e-05	0.00183	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	9.04e-05	0.00181	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	8.8e-05	0.00177	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	8.8e-05	0.00176	CbGpPWpGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	8.76e-05	0.00176	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	8.71e-05	0.00175	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	8.49e-05	0.0017	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	8.49e-05	0.0017	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	8.07e-05	0.00162	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	8.05e-05	0.00161	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	7.78e-05	0.00156	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	7.67e-05	0.00154	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	7.57e-05	0.00152	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	7.5e-05	0.0015	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	7.49e-05	0.0015	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PRSS1—pancreatic cancer	7.48e-05	0.0015	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	7.47e-05	0.0015	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	7.47e-05	0.0015	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	7.32e-05	0.00147	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	7.31e-05	0.00146	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	7.29e-05	0.00146	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—TNF—pancreatic cancer	7.29e-05	0.00146	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	7.22e-05	0.00145	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	7.06e-05	0.00141	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IFNA5—pancreatic cancer	7.04e-05	0.00141	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	7.03e-05	0.00141	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	6.97e-05	0.0014	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	6.9e-05	0.00138	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PRSS1—pancreatic cancer	6.76e-05	0.00136	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PPP2R5B—pancreatic cancer	6.65e-05	0.00133	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	6.6e-05	0.00132	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	6.52e-05	0.00131	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	6.52e-05	0.00131	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ARG2—pancreatic cancer	6.49e-05	0.0013	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	6.4e-05	0.00128	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	6.35e-05	0.00127	CbGpPWpGaD
Methyltestosterone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	6.1e-05	0.00122	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	6.07e-05	0.00122	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	5.94e-05	0.00119	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—VEGFA—pancreatic cancer	5.93e-05	0.00119	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TNF—pancreatic cancer	5.93e-05	0.00119	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ARG2—pancreatic cancer	5.86e-05	0.00118	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	5.85e-05	0.00117	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	5.83e-05	0.00117	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MEN1—pancreatic cancer	5.81e-05	0.00116	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	5.79e-05	0.00116	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	5.72e-05	0.00115	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—TYMP—pancreatic cancer	5.67e-05	0.00114	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	5.65e-05	0.00113	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	5.61e-05	0.00112	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—NOTCH4—pancreatic cancer	5.5e-05	0.0011	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	5.45e-05	0.00109	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—TGFB1—pancreatic cancer	5.44e-05	0.00109	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	5.4e-05	0.00108	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	5.4e-05	0.00108	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—HSPA1B—pancreatic cancer	5.25e-05	0.00105	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TP53—pancreatic cancer	5.23e-05	0.00105	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	5.18e-05	0.00104	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—TYMP—pancreatic cancer	5.13e-05	0.00103	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	5.09e-05	0.00102	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	4.99e-05	0.001	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.96e-05	0.000995	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	4.89e-05	0.000981	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.8e-05	0.000963	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—EZH2—pancreatic cancer	4.78e-05	0.000959	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	4.71e-05	0.000944	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.68e-05	0.000938	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—NOTCH3—pancreatic cancer	4.68e-05	0.000938	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GLP1R—pancreatic cancer	4.57e-05	0.000917	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—DPYD—pancreatic cancer	4.5e-05	0.000902	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.45e-05	0.000893	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—HSPA1A—pancreatic cancer	4.43e-05	0.000889	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	4.4e-05	0.000882	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	4.35e-05	0.000872	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PRSS1—pancreatic cancer	4.34e-05	0.000871	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SLC2A2—pancreatic cancer	4.27e-05	0.000856	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.23e-05	0.000848	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.22e-05	0.000847	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	4.21e-05	0.000844	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GLP1R—pancreatic cancer	4.13e-05	0.000828	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.08e-05	0.000817	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—DPYD—pancreatic cancer	4.07e-05	0.000815	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.05e-05	0.000813	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—CD44—pancreatic cancer	3.98e-05	0.000799	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	3.87e-05	0.000775	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IFNA1—pancreatic cancer	3.86e-05	0.000773	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SLC2A2—pancreatic cancer	3.86e-05	0.000773	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.82e-05	0.000765	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ARG2—pancreatic cancer	3.77e-05	0.000755	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.71e-05	0.000745	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.68e-05	0.000739	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PRSS1—pancreatic cancer	3.66e-05	0.000733	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IFNA2—pancreatic cancer	3.59e-05	0.00072	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—SMAD4—pancreatic cancer	3.53e-05	0.000707	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	3.37e-05	0.000676	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.36e-05	0.000673	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CD44—pancreatic cancer	3.31e-05	0.000663	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—TYMP—pancreatic cancer	3.29e-05	0.00066	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.24e-05	0.000649	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.21e-05	0.000643	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ARG2—pancreatic cancer	3.17e-05	0.000636	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GCG—pancreatic cancer	3.17e-05	0.000635	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CD44—pancreatic cancer	2.99e-05	0.000599	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—STK11—pancreatic cancer	2.98e-05	0.000597	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.93e-05	0.000587	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—MYC—pancreatic cancer	2.9e-05	0.000582	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.9e-05	0.000581	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GCG—pancreatic cancer	2.86e-05	0.000574	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.8e-05	0.000561	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—TYMP—pancreatic cancer	2.77e-05	0.000556	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	2.7e-05	0.000541	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—STK11—pancreatic cancer	2.69e-05	0.00054	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GLP1R—pancreatic cancer	2.65e-05	0.000532	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	2.63e-05	0.000527	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—DPYD—pancreatic cancer	2.61e-05	0.000523	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—NOTCH1—pancreatic cancer	2.6e-05	0.000521	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—TYMS—pancreatic cancer	2.56e-05	0.000514	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PLAU—pancreatic cancer	2.55e-05	0.000511	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.53e-05	0.000507	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	2.48e-05	0.000497	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PPARG—pancreatic cancer	2.45e-05	0.000492	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	2.41e-05	0.000484	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—TYMS—pancreatic cancer	2.32e-05	0.000464	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.29e-05	0.000458	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CG—pancreatic cancer	2.27e-05	0.000455	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—EGF—pancreatic cancer	2.24e-05	0.000449	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GLP1R—pancreatic cancer	2.23e-05	0.000448	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—DPYD—pancreatic cancer	2.2e-05	0.000441	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SLC2A2—pancreatic cancer	2.09e-05	0.000418	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—APOE—pancreatic cancer	2.08e-05	0.000418	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.06e-05	0.000414	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	2.05e-05	0.000412	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CD—pancreatic cancer	1.99e-05	0.0004	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.99e-05	0.000399	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.97e-05	0.000396	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.97e-05	0.000396	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CD44—pancreatic cancer	1.92e-05	0.000385	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—APOE—pancreatic cancer	1.88e-05	0.000378	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	1.88e-05	0.000377	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GCG—pancreatic cancer	1.84e-05	0.000369	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PPARG—pancreatic cancer	1.82e-05	0.000364	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.81e-05	0.000364	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.78e-05	0.000358	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CB—pancreatic cancer	1.74e-05	0.000348	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—STK11—pancreatic cancer	1.73e-05	0.000347	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.71e-05	0.000343	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CG—pancreatic cancer	1.7e-05	0.000341	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.68e-05	0.000336	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	1.65e-05	0.000332	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PPARG—pancreatic cancer	1.64e-05	0.000329	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CD44—pancreatic cancer	1.61e-05	0.000324	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.58e-05	0.000317	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.57e-05	0.000314	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GCG—pancreatic cancer	1.55e-05	0.00031	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.5e-05	0.0003	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CD—pancreatic cancer	1.49e-05	0.0003	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—TYMS—pancreatic cancer	1.49e-05	0.000298	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—STK11—pancreatic cancer	1.46e-05	0.000292	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	1.44e-05	0.000289	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	1.43e-05	0.000286	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MYC—pancreatic cancer	1.4e-05	0.00028	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SRC—pancreatic cancer	1.39e-05	0.000279	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.37e-05	0.000274	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—VEGFA—pancreatic cancer	1.36e-05	0.000272	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—NRAS—pancreatic cancer	1.34e-05	0.000268	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CB—pancreatic cancer	1.3e-05	0.000261	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTGS2—pancreatic cancer	1.29e-05	0.000259	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—TYMS—pancreatic cancer	1.25e-05	0.000251	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTEN—pancreatic cancer	1.25e-05	0.00025	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TGFB1—pancreatic cancer	1.24e-05	0.000249	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—APOE—pancreatic cancer	1.21e-05	0.000243	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.21e-05	0.000242	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.19e-05	0.000238	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—KRAS—pancreatic cancer	1.15e-05	0.000231	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.13e-05	0.000226	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTEN—pancreatic cancer	1.13e-05	0.000226	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	1.09e-05	0.000219	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CA—pancreatic cancer	1.06e-05	0.000212	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PPARG—pancreatic cancer	1.05e-05	0.000211	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—pancreatic cancer	1.02e-05	0.000205	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—APOE—pancreatic cancer	1.02e-05	0.000204	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—HRAS—pancreatic cancer	9.8e-06	0.000196	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—AKT1—pancreatic cancer	9.7e-06	0.000194	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.64e-06	0.000193	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	9.6e-06	0.000192	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CG—pancreatic cancer	9.19e-06	0.000184	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PPARG—pancreatic cancer	8.87e-06	0.000178	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	8.79e-06	0.000176	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CD44—pancreatic cancer	8.72e-06	0.000175	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—AKT1—pancreatic cancer	8.65e-06	0.000173	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	8.37e-06	0.000168	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GCG—pancreatic cancer	8.36e-06	0.000168	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTGS2—pancreatic cancer	8.29e-06	0.000166	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CD—pancreatic cancer	8.08e-06	0.000162	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	7.94e-06	0.000159	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—STK11—pancreatic cancer	7.86e-06	0.000158	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTEN—pancreatic cancer	7.23e-06	0.000145	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—AKT1—pancreatic cancer	7.18e-06	0.000144	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CB—pancreatic cancer	7.04e-06	0.000141	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTGS2—pancreatic cancer	6.98e-06	0.00014	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.76e-06	0.000136	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—AKT1—pancreatic cancer	6.49e-06	0.00013	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTEN—pancreatic cancer	6.09e-06	0.000122	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—APOE—pancreatic cancer	5.5e-06	0.00011	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	5.1e-06	0.000102	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.96e-06	9.95e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.79e-06	9.6e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.36e-06	8.75e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CA—pancreatic cancer	4.29e-06	8.61e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—AKT1—pancreatic cancer	4.17e-06	8.35e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.8e-06	7.62e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.77e-06	7.55e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—AKT1—pancreatic cancer	3.51e-06	7.03e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.29e-06	6.59e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.32e-06	4.65e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.89e-06	3.8e-05	CbGpPWpGaD
